₹100 tablet to prevent cancer regrowth developed by Tata Memorial Center

Date:

[ad_1]

Finding a cure for cancer has been an elusive goal so far, but it is not far away, with an unprecedented research from Tata claiming to have found a potential drug that can not only prevent cancer cells from reemerging , but also available at an affordable price. A pill worth Rs 100. Tata Memorial Hospital, through its new research, has developed a Dr Rajendra Badve, director of the Tata Memorial Centre, said in an interview with NDTV that 100 tablets would be given to reduce the side effects of cancer treatment therapy as well as to prevent relapse or recurrence of cancer. (Also Read | HTLS 2023: India will have the world’s best cancer care system in 5 years, says Vivek Wadhwa)

A decade-long research study by doctors at Tata Memorial Hospital (TMH) found that dying cancer cells after chemotherapy and radiotherapy release cell-free chromatin particles that can turn healthy cells into cancer.  (symbolic photo)(Twitter/Andevermot)
A decade-long research study by doctors at Tata Memorial Hospital (TMH) found that dying cancer cells after chemotherapy and radiotherapy release cell-free chromatin particles that can turn healthy cells into cancer. (symbolic photo)(Twitter/Andevermot)

Dr Badve said Tata doctors have been working for almost a decade on the tablet, which is likely to get approval from the Food Safety and Standards Authority of India (FSSAI) in June-July to reduce the side effects of cancer treatment. Is. The senior doctor said that once approved, the tablet could help reduce the side effects of treatments like chemotherapy by 50 percent and reduce the chances of cancer recurrence by 30%, which is the best so far according to the institute. The cheapest and most effective cancer treatment.

Hindustan Times – Your fastest source for breaking news! Read now.

A decade-long research study by doctors at Tata Memorial Hospital (TMH) found that dying cancer cells after chemotherapy and radiotherapy release cell-free chromatin particles that can turn healthy cells into cancer. According to the study, the pro-oxidant combination of resveratrol and copper helped control chromatin destruction and toxicity in patients undergoing chemotherapy, a Hindustan Times report said.

“We did a small experiment in which we took human breast cancer cells and transplanted them into immunocompromised mice,” said onco-surgeon-turned-scientist Dr Indranil Mitra, who led TMH doctors in the study. “Within six weeks, a small tumor formed. We divided the mice into three categories according to cancer treatment – ​​chemotherapy, radiotherapy and surgery. “We found that all three treatments increased chromatin in the mouse brain.”

“We found that the combination of resveratrol and copper helped destroy chromatin. We used the orally given combination in our study and found that it inhibited metastasis,” said Dr Mitra. “We now need to test it on humans to understand how we can improve the outcome of our patients and, if possible, the outcome of the general population of India,” said Dr. Rajendra Badve.

Recently Russian President Vladimir Putin announced that Russian scientists are close to developing cancer vaccines that will soon be available to patients

Dr. Badve told NDTV, “The research sheds light on the mechanisms of metastasis that we were unable to uncover for so long. What are the properties in cells that can lead to metastasis and what causes metastasis, we have discovered through this research. Through this both these things have been understood.” ,

However, people may have to wait a few years to take advantage of this new treatment to prevent cancer from recurring as Dr. Badwe said the trials will take at least 5-6 years.

[ad_2]

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Share post:

[tds_leads title_text="Subscribe" input_placeholder="Email address" btn_horiz_align="content-horiz-center" pp_checkbox="yes" pp_msg="SSd2ZSUyMHJlYWQlMjBhbmQlMjBhY2NlcHQlMjB0aGUlMjAlM0NhJTIwaHJlZiUzRCUyMiUyMyUyMiUzRVByaXZhY3klMjBQb2xpY3klM0MlMkZhJTNFLg==" f_title_font_family="653" f_title_font_size="eyJhbGwiOiIyNCIsInBvcnRyYWl0IjoiMjAiLCJsYW5kc2NhcGUiOiIyMiJ9" f_title_font_line_height="1" f_title_font_weight="700" f_title_font_spacing="-1" msg_composer="success" display="column" gap="10" input_padd="eyJhbGwiOiIxNXB4IDEwcHgiLCJsYW5kc2NhcGUiOiIxMnB4IDhweCIsInBvcnRyYWl0IjoiMTBweCA2cHgifQ==" input_border="1" btn_text="I want in" btn_tdicon="tdc-font-tdmp tdc-font-tdmp-arrow-right" btn_icon_size="eyJhbGwiOiIxOSIsImxhbmRzY2FwZSI6IjE3IiwicG9ydHJhaXQiOiIxNSJ9" btn_icon_space="eyJhbGwiOiI1IiwicG9ydHJhaXQiOiIzIn0=" btn_radius="3" input_radius="3" f_msg_font_family="653" f_msg_font_size="eyJhbGwiOiIxMyIsInBvcnRyYWl0IjoiMTIifQ==" f_msg_font_weight="600" f_msg_font_line_height="1.4" f_input_font_family="653" f_input_font_size="eyJhbGwiOiIxNCIsImxhbmRzY2FwZSI6IjEzIiwicG9ydHJhaXQiOiIxMiJ9" f_input_font_line_height="1.2" f_btn_font_family="653" f_input_font_weight="500" f_btn_font_size="eyJhbGwiOiIxMyIsImxhbmRzY2FwZSI6IjEyIiwicG9ydHJhaXQiOiIxMSJ9" f_btn_font_line_height="1.2" f_btn_font_weight="700" f_pp_font_family="653" f_pp_font_size="eyJhbGwiOiIxMyIsImxhbmRzY2FwZSI6IjEyIiwicG9ydHJhaXQiOiIxMSJ9" f_pp_font_line_height="1.2" pp_check_color="#000000" pp_check_color_a="#ec3535" pp_check_color_a_h="#c11f1f" f_btn_font_transform="uppercase" tdc_css="eyJhbGwiOnsibWFyZ2luLWJvdHRvbSI6IjQwIiwiZGlzcGxheSI6IiJ9LCJsYW5kc2NhcGUiOnsibWFyZ2luLWJvdHRvbSI6IjM1IiwiZGlzcGxheSI6IiJ9LCJsYW5kc2NhcGVfbWF4X3dpZHRoIjoxMTQwLCJsYW5kc2NhcGVfbWluX3dpZHRoIjoxMDE5LCJwb3J0cmFpdCI6eyJtYXJnaW4tYm90dG9tIjoiMzAiLCJkaXNwbGF5IjoiIn0sInBvcnRyYWl0X21heF93aWR0aCI6MTAxOCwicG9ydHJhaXRfbWluX3dpZHRoIjo3Njh9" msg_succ_radius="2" btn_bg="#ec3535" btn_bg_h="#c11f1f" title_space="eyJwb3J0cmFpdCI6IjEyIiwibGFuZHNjYXBlIjoiMTQiLCJhbGwiOiIxOCJ9" msg_space="eyJsYW5kc2NhcGUiOiIwIDAgMTJweCJ9" btn_padd="eyJsYW5kc2NhcGUiOiIxMiIsInBvcnRyYWl0IjoiMTBweCJ9" msg_padd="eyJwb3J0cmFpdCI6IjZweCAxMHB4In0="]

Popular

More like this
Related

Discover more from AyraNews24x7

Subscribe now to keep reading and get access to the full archive.

Continue reading